『Eagle's Eye View: Your Weekly CV Update From ACC.org』のカバーアート

Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle's Eye View: Your Weekly CV Update From ACC.org

著者： American College of Cardiology
無料で聴く

概要

 The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.American College of Cardiology Foundation. All rights reserved. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • New ACC/AHA Dyslipidemia Guidelines Released

    New ACC/AHA Dyslipidemia Guidelines Released
    2026/03/18

    In this week's View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off-label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. He then explores the REVNOVATE-COMPLEX-PCI study that investigates the benefits of intravascular imaging guidance for five years. Finally, Dr. Eagle summarizes the ACC/AHA's newly released clinical guidelines for managing dyslipidemia.

     Subscribe to Eagle's Eye View  

    続きを読む 一部表示
    8 分
  • Beta-Blocker vs. Calcium-Channel Blocker in HCM

    Beta-Blocker vs. Calcium-Channel Blocker in HCM
    2026/03/11
    In this week's View, Dr. Eagle looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment. He then explores lower heart failure (HF) hospitalization risk in patients with type 2 diabetes, comparing GLP-1RAs to DPP-4 inhibitors and similar outcomes with SGLT-2 inhibitors. Dr. Eagle then examines the use of shared decision-making and decision aids in percutaneous left atrial appendage occlusion (LAAO). Finally, the iModern trial, which compares immediate percutaneous coronary intervention (PCI) guided by instantaneous wave-free ratio (iFR) and deferred PCI guided by cardiac stress magnetic resonance imaging (MRI) in patients with STEMI and multivessel disease, is discussed.  Subscribe to Eagle's Eye View  
    続きを読む 一部表示
    9 分
  • Increased Mortality and TAVR; Wine Intake and CV Risk; PVI & Drug-Refractory Paroxysmal Atrial Fibrillation

    Increased Mortality and TAVR; Wine Intake and CV Risk; PVI & Drug-Refractory Paroxysmal Atrial Fibrillation
    2026/03/04
    In this week's View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR). He then explores the PREDIMED trial which found that adherence to the Mediterranean diet plus moderate wine intake was associated with reduced cardiovascular risk and mortality. Finally, Dr. Eagle examines 20-year outcomes for pulmonary vein isolation (PVI) in patients with drug-refractory paroxysmal atrial fibrillation (AFib).  Subscribe to Eagle's Eye View  
    続きを読む 一部表示
    7 分
まだレビューはありません